This podcast episode features Greg Myers, Chief Digital and Technology Officer at Bristol Myers Squibb, discussing the transformative role of AI in biopharma, its applications in drug discovery and clinical trials, and the organizational changes required to overcome skepticism and adapt to this rapidly evolving technology. Highlighting successful partnerships, particularly with AI startups and NVIDIA, Myers emphasizes the potential of AI to improve predictive modeling and patient outcomes while cautioning about the importance of responsible AI practices to address biases and data challenges. He concludes by forecasting a promising yet cautious outlook on AI's impact in healthcare, likening its progress to the early days of the internet.
